Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
847.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 11.00 (1.316%)
Market Cap: £798.83m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AuM Update

13 Apr 2026 07:00

RNS Number : 0699A
Polar Capital Holdings PLC
13 April 2026
 

13 April 2026 Polar Capital Holdings plc

AuM Update

 

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist active asset management group, today provides its regular quarterly update of its unaudited statement of Assets under Management ("AuM") for the financial year to 31 March 2026.

 

Group AuM (unaudited)

 

Polar Capital reports that as at 31 March 2026 its AuM was £30.6bn compared to £28.4bn at the end of December 2025, an increase of 8% over the quarter. In the quarter, AuM increased by net inflows of £1.4bn, fund performance and market movements of £0.8bn, offset by fund closures of £13m.

 

AuM movement in three months to 31 March 2026

Open ended

Funds

(£m)

Investment

Trusts

(£m)

Segregated mandates

(£m)

Total

(£m)

AuM at 1 January 2026

21,366

 

6,482

539

28,387

Net flows

 1,386

 (5)

62

1,443

Fund closures1

(13)

-

-

(13)

Market movement

and performance

685

128

3

816

Total AuM at 31 March 2026

23,424

6,605

604

30,633

 

 

 

AuM movement in twelve months to 31 March 2026

Open ended

Funds

(£m)

Investment

Trusts

(£m)

Segregated mandates

(£m)

Total

(£m)

AuM at 1 April 2025

15,994

4,846

569

21,409

Net flows

 1,233

 (237)

 (94)

 902

Corporate actions2

-

 (396)

-

(396)

Fund closures1

 (75)

-

-

 (75)

Market movement

and performance

 6,272

 2,392

 129

 8,793

Total AuM at 31 March 2026

23,424

6,605

604

30,633

1 Return of funds to investors upon the closure of the Polar Capital Emerging Market ex-China Stars Fund in February 2026, Polar Capital China Stars Fund in January 2026 and the Polar Capital Melchior European Opportunities Fund in November 2025.

2 Return of capital to investors in June 2025 as the Polar Capital Global Financials Trust underwent a 100% tender offer following which 44% of issued capital was tendered and in November 2025 when Polar Capital Global Healthcare Trust underwent a 100% tender offer following which 22% of issued capital was tendered.

 

 

Iain Evans, Chief Executive, commented:

"We have delivered a strong finish to the financial year, despite a backdrop of heightened geopolitical uncertainty and ongoing market volatility. Over the quarter, assets under management (AuM) increased by 8% to £30.6bn, up from £28.4bn at the end of December, supported by net inflows of £1.4bn.

 

"For the full financial year, AuM increased by 43% to £30.6bn, from £21.4bn at the end of March 2025, reflecting a combination of net inflows, fund performance and market movements. We delivered a second consecutive year of positive net inflows, totalling £902m (excluding corporate actions and fund closures), demonstrating the strength of our specialist investment capabilities.

 

"Flows during the quarter were broad-based, with several of our investment teams generating net inflows, led by Technology, Healthcare and Smart Energy. Net flows into our Global Technology (£722m) and Artificial Intelligence (£575m) funds remained particularly strong, driven by continued client interest in structural growth opportunities and supported by both increased allocations from existing clients and new client wins, notably across wealth and private bank channels in Europe and Asia.

 

"Our Healthcare strategies also contributed positively, including the launch of a new separately managed account in partnership with a Swiss wealth manager. In addition, Emerging Market Stars, Japan Value and Global Absolute Return funds each delivered net inflows, further highlighting the breadth of our platform.

 

"Net outflows were largely concentrated in North American (£97m), Global Insurance (£85m) and Asian Stars (£55m) funds, reflecting a small number of client-specific redemptions rather than any broader shift in demand or sentiment.

 

Outlook

"We have entered 2026 with positive net inflow momentum, although we remain mindful of the structural challenges facing the industry. Inflows were strongest in January and February, before moderating in March following the escalation of conflict in the Middle East. Encouragingly, positive momentum has continued into April to date.

"The geopolitical backdrop has become more uncertain, contributing to heightened market sensitivity, particularly in energy markets. Despite this, we remain confident in our positioning as a specialist boutique. As markets broaden and the pace of technological disruption, including AI, accelerates, the case for specialist active management is becoming increasingly compelling. Our focus on differentiated capabilities, deep expertise and disciplined execution positions us well to navigate the uncertainty and capture opportunities ahead for our clients and shareholders."

 

Polar Capital plans to announce its results for the financial year ended 31 March 2026 on 1 July 2026.

 

 

For further information please contact:

 

Polar Capital

Iain Evans (Chief Executive)

Samir Ayub (Chief Financial Officer)

 

+44 (0)20 7227 2700

 

Deutsche Numis - - Nomad and Joint Broker

Charles Farquhar

Duncan Monteith

Rajesh Iyer

 

+44 (0)20 7260 1000

 

Peel Hunt LLP - Joint Broker

Andrew Buchanan

Thomas Philpott

 

+44 (0)20 3597 8680

 

 

Camarco - PR

Ed Gascoigne-Pees

Jennifer Renwick

Phoebe Pugh

+44 (0)20 3757 4980

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAKLEFDFKEFA
Date   Source Headline
19th Mar 20194:42 pmRNSDirector/PDMR Shareholding
15th Mar 20194:28 pmRNSIssue of Equity
14th Mar 201912:08 pmRNSBlock Listing Application
13th Mar 20196:03 pmRNSForm 8.3 - Charter Court Financial Services Group
13th Mar 20194:18 pmRNSForm 8.3 - OneSavings Bank PLC
13th Mar 20194:09 pmRNSForm 8.3 - Charter Court Financial Services Group
1st Mar 20197:00 amRNSTotal Voting Rights
27th Feb 201910:00 amRNSIssue of Equity
20th Feb 20194:54 pmRNSIssue of Equity
18th Feb 201911:09 amRNSHolding(s) in Company
4th Feb 20199:43 amRNSBlock listing Interim Review
1st Feb 201911:41 amRNSTotal Voting Rights
29th Jan 20194:41 pmRNSSecond Price Monitoring Extn
29th Jan 20194:35 pmRNSPrice Monitoring Extension
28th Jan 20195:45 pmRNSIssue of Equity
28th Jan 20195:30 pmRNSDirector/PDMR Shareholding
10th Jan 201910:19 amRNSDirector/PDMR Shareholding
10th Jan 20197:00 amRNSAUM Update
2nd Jan 20199:49 amRNSTotal Voting Rights
12th Dec 20184:00 pmRNSIssue of Equity
27th Nov 20184:40 pmRNSSecond Price Monitoring Extn
27th Nov 20184:35 pmRNSPrice Monitoring Extension
26th Nov 20187:00 amRNSUnaudited Interim Results
22nd Nov 20185:00 pmRNSDirectorate Change
5th Nov 20187:01 amRNSNotice of Results
5th Nov 20187:00 amRNSChange of Nominated Adviser and Broker
1st Nov 20187:00 amRNSTotal Voting Rights
25th Oct 20185:26 pmRNSIssue of Equity
24th Oct 20184:52 pmRNSDirector/PDMR Shareholding
17th Oct 20185:49 pmRNSIssue of Equity
15th Oct 201812:38 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
12th Oct 20182:52 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
11th Oct 20184:42 pmRNSIssue of Equity
11th Oct 20187:01 amRNSCrystallisation of business unit & issue of shares
11th Oct 20187:00 amRNSAUM Update
3rd Oct 201810:24 amRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
19th Sep 201811:52 amRNSForm 8.3 - Jardine Lloyd Thompson Group
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
17th Aug 20189:27 amRNSDirectorate Change
6th Aug 20187:00 amRNSBlock listing Interim Review
1st Aug 20187:00 amRNSTotal Voting Rights
31st Jul 20185:57 pmRNSIssue of Equity
31st Jul 201811:29 amRNSDirector/PDMR Shareholding
25th Jul 20183:38 pmRNSDirectorate Change
25th Jul 20183:26 pmRNSResult of AGM
19th Jul 201811:13 amRNSForm 8.3 - Consort Medical Plc
18th Jul 20184:21 pmRNSDirector/PDMR Shareholding
18th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
17th Jul 201810:58 amRNSForm 8.3 - Consort Medical Plc
16th Jul 20183:44 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.